1. Academic Validation
  2. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol

Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol

  • Am J Chin Med. 2022 Oct 29;1-21. doi: 10.1142/S0192415X22500902.
Wei Yu 1 Chunjuan Chen 2 Chenxi Xu 1 De Xie 1 Qiang Wang 1 Weidong Liu 1 Hairong Zhao 1 Furong He 1 Bingyang Chen 1 Yuemei Xi 1 Yunbo Yan 1 Linqian Yu 1 Jidong Cheng 1
Affiliations

Affiliations

  • 1 Department of Internal Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, P. R. China.
  • 2 Department of Cardiology, The Second Affiliated Hospital of Shantou, University Medical College, Shantou, P. R. China.
Abstract

Doxorubicin (DOX) is a most common anthracycline chemotherapeutic agent; however, its clinical efficacy is limited due to its severe and irreversible cardiotoxicity. Ferroptosis, characterized by iron overload and lipid peroxidation, plays a pivotal role in DOX-induced cardiotoxicity. Resveratrol (RSV) displays cardioprotective and Anticancer effects, owing to its antioxidative and anti-inflammatory properties. However, the role and mechanism of RSV in DOX-mediated Ferroptosis in cardiomyocytes is unclear. This study showed that DOX decreased cell viability, increased iron accumulation and lipid peroxidation in H9c2 cells; however, these effects were reversed by RSV and Ferroptosis inhibitor ferrostatin-1 (Fer-1) pre-treatment. Additionally, RSV significantly increased the cell viability of H9c2 cells treated with Ferroptosis inducers Erastin (Era) and RSL3. Mechanistically, RSV inhibited mitochondrial Reactive Oxygen Species (mtROS) overproduction and upregulated the p62-NRF2/HO-1 pathway. RSV-induced NRF2 activation was partially dependent on p62, and the selective inhibition of p62 (using p62-siRNA interference) or NRF2 (using NRF2 specific inhibitor, ML385) significantly abolished the anti-ferroptosis function of RSV. Furthermore, RSV treatment protected mice against DOX-induced cardiotoxicity, including significantly improving left ventricular function, ameliorating myocardial fibrosis and suppressing Ferroptosis. Consistent with in vitro results, RSV also upregulated the p62-NRF2/HO-1 expression, which was inhibited by DOX, in the myocardium. Notably, the protective effect of RSV in DOX-mediated Ferroptosis was similar to that of Fer-1 in vitro and in vivo. Thus, the p62-NRF2 axis plays a critical role in regulating DOX-induced Ferroptosis in cardiomyocytes. RSV as a potent p62 activator has potential as a therapeutic target in preventing DOX-induced cardiotoxicity via Ferroptosis modulation.

Keywords

Cardiotoxicity; Doxorubicin; Ferroptosis; Polyphenolic Compound; Resveratrol; p62-NRF2 Axis.

Figures
Products